Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -1.400% | -18.857% | 3.650% | 6.767% | -14.458% | -0.699% | -68.962% |
| Northwest Biotherapeutics Inc. | 0.000% | 3.614% | 1.176% | -14.851% | -16.505% | -64.609% | -85.172% |
| Celldex Therapeutics | -1.180% | 8.205% | 30.315% | 78.919% | 50.455% | 3.438% | 18.468% |
News
Analysts Just Raised Price Targets On These 3 Semiconductor Equipment Stocks
Key Points
- Interested in Advanced Energy Industries, Inc.? Here are five stocks we like better.
- Susquehanna raised its wafer fab equipment market forecast to $250 billion by 2028, a 20% increase
The Case for and Against Buying NuScale Right Now
Advanced nuclear company NuScale Power (NYSE: SMR) is developing small modular reactors (SMRs), which are manufactured in a factory and deployed in multiples.
At its core, NuScale is trying to make
Investing $5,000 Into Each of These 3 Stocks 10 Years Ago Would Have Created a Portfolio Worth $1.8 Million Today
Investing in many different types of stocks can be a great way to minimize your risk while also giving you a chance to generate great returns in the long run. That's because it isn't always obvious